Abstract
Although randomized trials have shown that electroconvulsive therapy (ECT) is an effective and underused treatment for mood disorders, its impact on inpatient length of stay (LOS) and hospital costs are not fully understood. We analyzed private insurance claims of patients hospitalized for mood disorders who had continuous insurance for three months prior to an index hospitalization and six months after discharge (N = 24,249). Propensity score weighted linear models were used to examine the association of any ECT use, the number of ECT treatments, and time to first ECT treatment, with LOS and hospital costs adjusting for potential confounders. Three months prior to the index hospitalization, patients who subsequently received ECT had more than double the total healthcare costs and bed days ($12,669 vs. $6,333 and 4.5 vs. 0.92 days, p < .001) of the other group. During their index admission, patients receiving ECT had longer LOS (16.1 vs. 5.8 days, p < .001) and three times greater hospital costs ($28,607 vs. $8,708, p < .001). Analyses adjusted for other group differences showed a dose–response relationship between the number of ECT treatments and LOS and hospital costs. Receipt of ECT was associated with increased LOS by 4 to 29 days depending on the number of ECT treatments and increasing total hospital costs from $5,767 to $52,717. Receipt of any ECT and the number of treatments during hospitalization were associated with markedly increased LOS, hospital admission costs, and post-discharge costs. Cost-effectiveness of ECT may be enhanced by shifting treatments to outpatient settings when possible.
Similar content being viewed by others
References
Case, B. G., Bertollo, D. N., Laska, E. M., Price, L. H., Siegel, C. E., Olfson, M., & Marcus, S. C. (2013). Declining use of electroconvulsive therapy in United States general hospitals. Biological Psychiatry, 73(2), 119–126. https://doi.org/10.1016/j.biopsych.2012.09.005
Centers for Medicare and Medicaid Services. (2019). Inpatient psychiatric facility prospective payment system. Retrieved February 22, 2020 from https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/Downloads/Inpatient-Psychiatric-Facility-Prospective-Payment-System-Text-Only.pdf
Dierckx, B., Heijnen, W. T., van den Broek, W. W., & Birkenhaager, T. K. (2012). Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: A meta-analysis. Bipolar Disorders, 14(2), 146–150. https://doi.org/10.1111/j.1399-5618.2012.00997.x
Fink, M., Kellner, C. H., & McCall, W. V. (2014). The role of ECT in suicide prevention. The Journal of ECT, 30(1), 5–9. https://doi.org/10.1097/YCT.0b013e3182a6ad0d
Hermann, R. C., Dorwart, R. A., Hoover, C. W., & Brody, J. (1995). Variation in ECT use in the United-States. American Journal of Psychiatry, 152(6), 869–875.
Husain, M. M., Rush, A. J., Fink, M., Knapp, R., Petrides, G., Rummans, T., Biggs, M. M., O’Connor, K., Rasmussen, K., Litle, M., Zhao, W., Bernstein, H. J., Smith, G., Mueller, M., McClintock, S. M., Bailine, S. H., & Kellner, C. H. (2004). Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A Consortium for Research in ECT (CORE) report. The Journal of Clinical Psychiatry, 65(4), 485–491.
Kellner, C. H., Greenberg, R. M., Murrough, J. W., Bryson, E. O., Briggs, M. C., & Pasculli, R. M. (2012). ECT in treatment-resistant depression. American Journal of Psychiatry, 169(12), 1238–1244. https://doi.org/10.1176/appi.ajp.2012.12050648
Ma, Y. R., Rosenheck, R., Fan, N., & He, H. B. (2019). Rates and patient characteristics of electroconvulsive therapy in China and comparisons with the United States. The Journal of ECT, 35(4), 251–257. https://doi.org/10.1097/Yct.0000000000000589
Medicare Payment Advisory Commission. (2010). Report to the congress: Aligning incentives in medicare. Retrieved February 22, 2020 from http://medpac.gov/docs/default-source/reports/Jun10_EntireReport.pdf
Olfson, M., Marcus, S., Sackeim, H. A., Thompson, J., & Pincus, H. A. (1998). Use of ECT for the inpatient treatment of recurrent major depression. American Journal of Psychiatry, 155(1), 22–29. https://doi.org/10.1176/Ajp.155.1.22
Patel, R. S., Sreeram, V., Thakur, T., Bachu, R., & Youssef, N. A. (2019). A national study for regional variation of inpatient ECT utilization from 4,411 hospitals across the United States. Annals of Clinical Psychiatry, 31(3), 200–208.
Rasmussen, K. G. (2011). Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression. The Journal of ECT, 27(1), 51–54. https://doi.org/10.1097/YCT.0b013e3181da84c6
Rhee, T. G., Olfson, M., Sint, K., & Wilkinson, S. T. (2020). Characterization of the quality of electroconvulsive therapy among older medicare beneficiaries. The Journal of Clinical Psychiatry. https://doi.org/10.4088/JCP.19m13186
Ross, E. L., Zivin, K., & Maixner, D. F. (2018). Cost-effectiveness of electroconvulsive therapy vs pharmacotherapy/psychotherapy for treatment-resistant depression in the United States. JAMA Psychiatry, 75(7), 713–722. https://doi.org/10.1001/jamapsychiatry.2018.0768
Sackeim, H. A. (2017). Modern electroconvulsive therapy vastly improved yet greatly underused. JAMA Psychiatry, 74(8), 779–780. https://doi.org/10.1001/jamapsychiatry.2017.1670
Sackeim, H. A., Prudic, J., Nobler, M. S., Fitzsimons, L., Lisanby, S. H., Payne, N., Berman, R. M., Brakemeier, E. L., Perera, T., & Devanand, D. P. (2008). Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimulation, 1(2), 71–83. https://doi.org/10.1016/j.brs.2008.03.001
Slade, E. P., Jahn, D. R., Regenold, W. T., & Case, B. G. (2017). Association of electroconvulsive therapy with psychiatric readmissions in US hospitals. JAMA Psychiatry, 74(8), 798–804. https://doi.org/10.1001/jamapsychiatry.2017.1378
Weiner, R. D. C. C., Fochtmann, L. J., Greenberg, R. M., Isenberg, K. E., Kellner, C. H., Sackeim, H. A., & Moench, L. (2001). The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging (2nd ed.). American Psychiatric Association.
Wilkinson, S. T., Agbese, E., Leslie, D. L., & Rosenheck, R. A. (2018). Identifying recipients of electroconvulsive therapy: Data from privately insured Americans. Psychiatric Services, 69(5), 542–548. https://doi.org/10.1176/appi.ps.201700364
Acknowledgements
The authors thank Samuel Wilkinson, MD (Yale Medical School, New Haven, USA), for his insights on the study methodology.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Agbese, E., Leslie, D.L., Ba, D.M. et al. Does Electroconvulsive Therapy for Patients with Mood Disorders Extend Hospital Length of Stays and Increase Inpatient Costs?. Adm Policy Ment Health 49, 71–78 (2022). https://doi.org/10.1007/s10488-021-01145-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10488-021-01145-3